In this roundtable discussion, Drs. Gerald Prager, Tanios Bekaii-Saab, and Eric Van Cutsem examine the safety and efficacy profiles of the available agents for patients who have failed first- and second-line therapy, provide insight into how to manage adverse effects, and elucidate how best to incorporate said agents in the appropriate sequence, either in combination or alone, when they are available.
Earn CME Credit for this activity: [ Ссылка ]
© 2017 Imedex, LLC.
